American Portfolios Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-464
Closed -$82.2K 2931
2020
Q1
$82.2K Sell
464
-41
-8% -$7.72K 0.01% 957
2019
Q4
$96.5K Buy
505
+13
+3% +$2.35K 0.01% 1047
2019
Q3
$82.8K Sell
492
-1,596
-76% -$260K 0.01% 1077
2019
Q2
$350K Sell
2,088
-1,102
-35% -$153K 0.03% 518
2019
Q1
$467K Buy
3,190
+266
+9% +$38.6K 0.04% 386
2018
Q4
$391K Sell
2,924
-470
-14% -$77K 0.05% 338
2018
Q3
$646K Sell
3,394
-818
-19% -$150K 0.07% 254
2018
Q2
$702K Buy
4,212
+576
+16% +$92.5K 0.1% 213
2018
Q1
$612K Buy
3,636
+317
+10% +$53.2K 0.09% 221
2017
Q4
$543K Buy
+3,319
New +$596K 0.09% 232

Other funds holding AGN

American Portfolios Advisors's AGN Position: Q2 2020 in Review

American Portfolios Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 464 shares — an estimated $82.2K sold.

American Portfolios Advisors first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $702K in Q2 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • American Portfolios Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • American Portfolios Advisors sold 464 Allergan plc shares in Q2 2020, an estimated $82.2K.
  • American Portfolios Advisors first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • American Portfolios Advisors's Allergan plc position peaked at $702K in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on American Portfolios Advisors's 13F filing for Q2 2020, filed 24 Mar 2023.